Literature DB >> 22337933

Intra-individual neurocognitive variability confers risk of dependence in activities of daily living among HIV-seropositive individuals without HIV-associated neurocognitive disorders.

Erin E Morgan1, Steven Paul Woods, Igor Grant.   

Abstract

Although HIV-associated neurocognitive disorders (HAND) are the strong predictors of everyday functioning difficulties, approximately half of all functionally impaired individuals are labeled "neurocognitively normal" according to the standard neuropsychological measures, suggesting that novel predictors of functional problems in this prevalent subgroup are needed. The present study hypothesized that increased neurocognitive intra-individual variability as indexed by dispersion would be associated with poor daily functioning among 82 persons with HIV infection who did not meet research criteria for HAND. An intra-individual standard deviation was calculated across the demographically adjusted T-scores of 13 standard neuropsychological tests to represent dispersion, and functional outcomes included self-reported declines in basic and instrumental activities of daily functioning (basic activity of daily living [BADL] and instrumental activity of daily living [IADL], respectively) and medication management. Dispersion was a significant predictor of medication adherence and dependence in both BADL and IADL, even when other known predictors of functional status (i.e., age, affective distress, and indices of disease severity) were included in the models. As a significant and unique predictor of a performance on the range of daily functioning activities, neurocognitive dispersion may be indicative of deficient cognitive control expressed as inefficient regulation of neurocognitive resources in the context of competing functional demands. As such, dispersion may have clinical utility in detecting risk for functional problems among HIV-infected individuals without HAND.

Entities:  

Mesh:

Year:  2012        PMID: 22337933      PMCID: PMC3329179          DOI: 10.1093/arclin/acs003

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  44 in total

1.  Norms for letter and category fluency: demographic corrections for age, education, and ethnicity.

Authors:  J A Gladsjo; C C Schuman; J D Evans; G M Peavy; S W Miller; R K Heaton
Journal:  Assessment       Date:  1999-06

2.  White matter hyperintensities and within-person variability in community-dwelling adults aged 60-64 years.

Authors:  David Bunce; Kaarin J Anstey; Helen Christensen; Keith Dear; Wei Wen; Perminder Sachdev
Journal:  Neuropsychologia       Date:  2007-02-20       Impact factor: 3.139

3.  Action (verb) fluency: test-retest reliability, normative standards, and construct validity.

Authors:  Steven Paul Woods; J Cobb Scott; Danielle A Sires; Igor Grant; Robert K Heaton; Alexander I Tröster
Journal:  J Int Neuropsychol Soc       Date:  2005-07       Impact factor: 2.892

4.  Drug use and medication adherence among HIV-1 infected individuals.

Authors:  Charles H Hinkin; Terry R Barclay; Steven A Castellon; Andrew J Levine; Ramani S Durvasula; Sarah D Marion; Hector F Myers; Douglas Longshore
Journal:  AIDS Behav       Date:  2007-03

5.  Action (verb) fluency predicts dependence in instrumental activities of daily living in persons infected with HIV-1.

Authors:  Steven Paul Woods; Erin E Morgan; Matthew Dawson; J Cobb Scott; Igor Grant
Journal:  J Clin Exp Neuropsychol       Date:  2006-08       Impact factor: 2.475

6.  The ecological validity of tests of executive function.

Authors:  P W Burgess; N Alderman; J Evans; H Emslie; B A Wilson
Journal:  J Int Neuropsychol Soc       Date:  1998-11       Impact factor: 2.892

7.  Construct validity of Hopkins Verbal Learning Test-Revised component process measures in an HIV-1 sample.

Authors:  Steven Paul Woods; J Cobb Scott; Matthew S Dawson; Erin E Morgan; Catherine L Carey; Robert K Heaton; Igor Grant
Journal:  Arch Clin Neuropsychol       Date:  2005-09-29       Impact factor: 2.813

Review 8.  The shifting patterns of HIV encephalitis neuropathology.

Authors:  I P Everall; L A Hansen; E Masliah
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

9.  Neuropsychiatric predictors of return to work in HIV/AIDS.

Authors:  Wilfred G van Gorp; Judith G Rabkin; Stephen J Ferrando; Jim Mintz; Elizabeth Ryan; Thomas Borkowski; Martin McElhiney
Journal:  J Int Neuropsychol Soc       Date:  2007-01       Impact factor: 2.892

10.  Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues.

Authors:  Robert Perneczky; Corina Pohl; Christian Sorg; Julia Hartmann; Katja Komossa; Panagiotis Alexopoulos; Stefan Wagenpfeil; Alexander Kurz
Journal:  Age Ageing       Date:  2006-03-02       Impact factor: 10.668

View more
  23 in total

1.  Intraindividual variability in neuropsychological performance predicts cognitive decline and death in HIV.

Authors:  Ariana E Anderson; Jacob D Jones; Nicholas S Thaler; Taylor P Kuhn; Elyse J Singer; Charles H Hinkin
Journal:  Neuropsychology       Date:  2018-09-13       Impact factor: 3.295

2.  Habitual prospective memory in HIV disease.

Authors:  Katie L Doyle; Erica Weber; Erin E Morgan; Shayne Loft; Clint Cushman; Javier Villalobos; Elaine Johnston; Steven Paul Woods
Journal:  Neuropsychology       Date:  2015-03-02       Impact factor: 3.295

3.  White matter hyperintensities correlate to cognition and fiber tract integrity in older adults with HIV.

Authors:  Christa Watson; Edgar Busovaca; Jessica M Foley; I Elaine Allen; Christopher G Schwarz; Neda Jahanshad; Talia M Nir; Pardis Esmaeili-Firidouni; Benedetta Milanini; Howard Rosen; Owen T Carmichael; Paul M Thompson; Victor G Valcour
Journal:  J Neurovirol       Date:  2017-01-18       Impact factor: 2.643

Review 4.  Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action.

Authors:  Erica Weber; Kaitlin Blackstone; Steven Paul Woods
Journal:  Neuropsychol Rev       Date:  2013-02-16       Impact factor: 7.444

5.  Time estimation and production in HIV-associated neurocognitive disorders (HAND).

Authors:  Katie L Doyle; Erin E Morgan; Erica Weber; Steven Paul Woods
Journal:  J Int Neuropsychol Soc       Date:  2015-02       Impact factor: 2.892

Review 6.  Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment.

Authors:  Kathryn N Devlin; Tania Giovannetti
Journal:  Neuropsychol Rev       Date:  2017-05-24       Impact factor: 7.444

7.  Measures of Physical and Mental Independence Among HIV-Positive Individuals: Impact of Substance Use Disorder.

Authors:  Bianca Christensen; Zijian Qin; Desiree A Byrd; Fang Yu; Susan Morgello; Benjamin B Gelman; David J Moore; Igor Grant; Elyse J Singer; Howard S Fox; Lorena Baccaglini
Journal:  AIDS Res Hum Retroviruses       Date:  2017-04-10       Impact factor: 2.205

8.  Heterogeneous ability profiles may be a unique indicator of impending cognitive decline.

Authors:  Timothy A Salthouse; Andrea Soubelet
Journal:  Neuropsychology       Date:  2014-05-05       Impact factor: 3.295

Review 9.  Aging with HIV-1 Infection: Motor Functions, Cognition, and Attention--A Comparison with Parkinson's Disease.

Authors:  S DeVaughn; E M Müller-Oehring; B Markey; H M Brontë-Stewart; T Schulte
Journal:  Neuropsychol Rev       Date:  2015-11-17       Impact factor: 7.444

10.  Cortical brain atrophy and intra-individual variability in neuropsychological test performance in HIV disease.

Authors:  Lindsay J Hines; Eric N Miller; Charles H Hinkin; Jeffery R Alger; Peter Barker; Karl Goodkin; Eileen M Martin; Victoria Maruca; Ann Ragin; Ned Sacktor; Joanne Sanders; Ola Selnes; James T Becker
Journal:  Brain Imaging Behav       Date:  2016-09       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.